FMOD and systemic sclerosis: Moreover, FMOD-induced myofibroblast apoptosis could also be beneficial for other pathologies associated with myofibroblast persistence, including autoimmune rheumatic diseases, such as systemic sclerosis, rheumatoid arthritis, as well as liver, kidney, and muscle fibrosis10,59.